-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Esmethadone Hydrochloride in Restless Legs Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Esmethadone Hydrochloride in Restless Legs Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Esmethadone Hydrochloride in Restless Legs Syndrome Drug Details: REL-1017 (D-methadone)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lonafarnib in Hepatitis D
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lonafarnib in Hepatitis D report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lonafarnib in Hepatitis D Drug Details: Lonafarnib (Zokinvy) is a synthetic tricyclic...
-
Company Insights
NewCaixaBank SA – Digital Transformation Strategies
CaixaBank SA Digital Transformation Strategies Overview CaixaBank is exploring the use of advanced technologies such as blockchain, artificial intelligence, big data, and robotics to increase its operational flexibility and efficiency. AI, big data, cloud, and blockchain are among the key technologies under focus for the company. The annual ICT spending of CaixaBank was estimated at $1.5 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. CaixaBank SA...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Calcipotriene in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Calcipotriene in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Calcipotriene in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: Calcipotriene (calcipotriol)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ropeginterferon Alfa-2B LA in Hepatitis D
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ropeginterferon Alfa-2B LA in Hepatitis D report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ropeginterferon Alfa-2B LA in Hepatitis D Drug Details: Ropeginterferon...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KB-408 in Alpha-1 Antitrypsin Deficiency (A1AD) Drug Details: KB-408 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Immune Globulin (Human) in Tachycardia (Tachyarrhythmias)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Immune Globulin (Human) in Tachycardia (Tachyarrhythmias) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Immune Globulin (Human) in Tachycardia (Tachyarrhythmias) Drug Details: Human Immunoglobulin...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Cycloserine + Lurasidone Hydrochloride) in Bipolar Disorder (Manic Depression)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Cycloserine + Lurasidone Hydrochloride) in Bipolar Disorder (Manic Depression) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Cycloserine + Lurasidone Hydrochloride) in Bipolar Disorder...
-
Analyst Opinions
AI Compute – How Chips Drive Next Industrial Leap
AI Chips Trend Analysis Report Overview GlobalData's "AI Compute: How Chips Drive Next Industrial Leap," innovation radar report explores the transformative impact of semiconductor chip innovations, particularly AI chips, across various industries such as healthcare, telecom, and energy & utilities. The report illuminates how advanced chips are enhancing computational power, enabling improved analytics, and driving automation. By reshaping industrial processes, these technologies are boosting efficiency and fostering innovation. The “AI Compute” report provides strategic insights to help businesses capitalize on...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orismilast in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Orismilast in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orismilast in Ulcerative Colitis Drug Details: Orismilast (UNI-50001) is under development for...